CLINICAL_TRIALS
withdrawal
· 2017-10-06
Clinical Trial Update: Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment [Phase 1]
Summary
A Phase 1 trial sponsored by the National Institute on Drug Abuse evaluating varenicline for tobacco addiction and abstinence-induced cognitive impairment has b…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Drug Addiction | Phase 1 | Status: WITHDRAWN